Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
It seems strange that a company with little positive news and a limited outlook in a sector surrounded by sharp-toothed competition would be doing well. But that’s just what Yahoo! (Nasdaq: YHOO) has been doing over the past two weeks.
With the arrival of its new CEO, Carol Bartz, investors seem to have given YHOO another shot. And they’ve given her some distance after disastrous founder/CEO Jerry Yang’s “crash and burn.”
Even though Bartz hasn’t made any definitive statements of her specific intent, the stock has done well. Over the past two weeks Yahoo! has moved up almost 20% while the Nasdaq has added only 3.5%. Clearly investors expect better results from her, and are hoping for it.
This comes as Google (Nasdaq: GOOG) and Microsoft (Nasdaq: MSFT) circle their wagons – And circle like vultures. Yahoo’s competitors must realize they are at a precipice where their next steps (or missteps) could decide who rules Web 3.0.
Google has been leading the pack lately with positive news on that front, and it continues to pour in.
The best piece of advice that we can think for Yahoo! to heed is this: Look to the successful web profit models. If you can figure out how to provide a content, platform, or product that will enable them to make more money – you will survive.
If you don’t, and if you’re clinging to the last vestiges of Web 1.2 , then I’d prepare to go the way of beta, the 8-track, the floppy disk and Jerry Yang.
Companies mentioned in this article: YHOO, GOOG and MSFT.
- Yahoo! Lets Go, Google Takes Over
- Microsoft’s (Nasdaq: MSFT) Miss Shouldn’t Surprise
- Google Takes MSFT Head on
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed